CNB
FLNA

City National Bank’s Filana Therapeutics FLNA Stock Holding History

City National Bank’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$22K Sell
1,714
-25
-1% -$316 ﹤0.01% 826
2015
Q2 		$21K Buy
1,739
+25
+1% +$343 ﹤0.01% 854
2015
Q1 		$23K Buy
+1,714
New +$23.1K ﹤0.01% 869

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

City National Bank's FLNA Position: Q3 2015 in Review

City National Bank reduced its Filana Therapeutics (FLNA) stake by 1.4% in Q3 2015, selling an estimated $316 and leaving 1,714 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #826.

City National Bank first reported a position in FLNA in Q1 2015 and has held it in 3 quarters since. The position peaked at $23K in Q1 2015. 49 funds tracked by Wall St. Rank hold FLNA as of Q3 2015.

  • City National Bank held 1,714 shares of Filana Therapeutics worth $22K as of Q3 2015.
  • City National Bank sold 25 Filana Therapeutics shares in Q3 2015, an estimated $316.
  • Filana Therapeutics made up ﹤0.01% of City National Bank's portfolio in Q3 2015, its #826 holding.
  • City National Bank first reported a position in Filana Therapeutics in Q1 2015 and has held it in 3 quarters since.
  • City National Bank's Filana Therapeutics position peaked at $23K in Q1 2015.
  • 49 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.